NCT03241433: HALT-AF

High-Intensity Aerobic Lifelong Training--AF

Completed NA Last updated 20 December 2019

What this trial tests

NA trial testing High intensity interval training in Atrial Fibrillation in 60 participants. Completed in 18 December 2019.

Timeline

1 May 2018

Primary endpoint
18 December 2019

18 December 2019

Quick facts

Lead sponsor	University of Minnesota
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	60
Start date	1 May 2018
Primary completion	18 December 2019
Estimated completion	18 December 2019
Sites	1 location across United States

Drugs / interventions tested

• High intensity interval training
• Moderate intensity continuous training
• No Exercise

Conditions studied

• Atrial Fibrillation — all drugs for Atrial Fibrillation →

Sponsor

University of Minnesota

Who can join

Adults 18 to 65, any sex, with Atrial Fibrillation. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is a single-center RCT. Potential subjects with symptomatic non-permanent AF will be enrolled to determine the effect of sprint interval training (SIT) in comparison to moderate-intensity continuous training (MICT) and non-exercise control in reducing AF burden. The Investigators will enroll 60 patients during the first 12 months of the study. Baseline data collection will be conducted during the first month after enrollment. After baseline data collection, subjects will be randomized (1:1:1) to SIT vs. MICT vs. non-exercise controls. The exercise training will last for 3 months followed by final data collection which will be completed in 1 month.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.